News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
65 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (18664)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1140)
Day
1 (65)
3 (19)
4 (205)
5 (197)
6 (190)
7 (229)
8 (170)
10 (33)
11 (150)
12 (194)
13 (208)
14 (261)
15 (58)
17 (52)
18 (160)
19 (145)
20 (146)
21 (119)
22 (102)
24 (37)
25 (10)
26 (177)
27 (191)
28 (158)
29 (79)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
3
4
5
6
7
8
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
31
Press Releases
Fulgent Reports First Quarter 2026 Financial Results
May 1, 2026
·
15 min read
Press Releases
Ionis to present at upcoming investor conferences - May 1, 2026
May 1, 2026
·
1 min read
Earnings
Amgen positions MariTide as potential ‘best monthly’ obesity drug
Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own investigational obesity asset MariTide, which could open up monthly or more infrequent dosing schedules.
May 1, 2026
·
2 min read
·
Tristan Manalac
Press Releases
InflaRx to Report First Quarter 2026 Results on May 7, 2026
May 1, 2026
·
5 min read
Press Releases
Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week
May 1, 2026
·
7 min read
Press Releases
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS)
May 1, 2026
·
10 min read
Press Releases
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
May 1, 2026
·
9 min read
Press Releases
Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET
May 1, 2026
·
1 min read
Press Releases
Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference
May 1, 2026
·
1 min read
Press Releases
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 1, 2026
May 1, 2026
·
1 min read
Previous
5 of 7
Next
